COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 1639: Articles 16381-16390  | Next

Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patients.
Sposito, B., Broggi, A., Pandolfi, L., Crotta, S., Ferrarese, R., Sisti, S., Clementi, N., Ambrosi, A., Liu, E., Frangipane, V., Saracino, L., Marongiu, L., Facchini, F., Bottazzi, A., Fossali, T., Colombo, R., Clementi, M., Tagliabue, E., Pontiroli, A., Meloni, F., Wack, A., Mancini, N., Zanoni, I.
10.1101/2021.03.30.437173 — Posted: 2021-03-30
Rapid characterization of spike variants via mammalian cell surface display
Javanmardi, K., Chou, C.-W., Terrace, C., Annapareddy, A., Kaoud, T. S., Guo, Q., Lutgens, J., Zorkic, H., Horton, A. P., Gardner, E. C., Nguyen, G., Boutz, D. R., Goike, J., Voss, W. N., Kuo, H.-C., Dalby, K. N., Gollihar, J. D., Finkelstein, I. J.
10.1101/2021.03.30.437622 — Posted: 2021-03-30
Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context.
Prince, T., Dong, X., Penrice-Randal, R., Randle, N., Hartley, C., Goldswain, H., Jones, B., Semple, M. G., Baillie, J. K., Openshaw, P. J. M., Turtle, L., ISARIC4C Investigators, , Hughes, G., Anderson, E., Patterson, E. I., Druce, J., Screaton, G., Carroll, M., Stewart, J. P., Hiscox, J. A.
10.1101/2021.03.30.437704 — Posted: 2021-03-30
A recombinant receptor-binding domain in trimeric form generates completely protective immunity against SARS-CoV-2 infection in nonhuman primates
Yang, L., Tian, D., Han, J.-b., Fan, W., Zhang, Y., Li, Y., Sun, W., Wei, Y., Tian, X., Yu, D.-d., Feng, X.-l., Cheng, G., Zheng, Y.-t., Bi, Y., Liu, W.
10.1101/2021.03.30.437647 — Posted: 2021-03-30
Development and validation of the RCOS prognostic index: a bedside multivariable logistic regression model to predict hypoxaemia or death in patients with of SARS-CoV-2 infection
Alvarez-Uria, G., Gandra, S., Gurram, V. R., Reddy, R. P., Midde, M., Kumar, P., Arce, K. E.
10.1101/2021.03.29.21254393 — Posted: 2021-03-30
IVERMECTIN REPROPOSING FOR COVID-19 TREATMENT OUTPATIENTS IN MILD STAGE IN PRIMARY HEALTH CARE CENTERS
Chahla, R. E., Medina Ruiz, L., Mena, T., Brepe, Y., Terranova, P., Ortega, E. S., Barrenechea,, G. G., Goroso, D. G., Peral de Bruno, M. d. l. A.
10.1101/2021.03.29.21254554 — Posted: 2021-03-30
Factors preventing SARS-CoV-2 transmission during unintentional exposure in a GP practice, Germany, 2020
Boender, T. S., Bender, J. K., Krueger, A., Michaelis, K., Buchholz, U.
10.1101/2021.03.17.21251046 — Posted: 2021-03-30
A patient satisfaction survey and educational package to improve the care of people hospitalised with COVID-19: an observational study, Liverpool, UK
Ahmed, M. S., Hicks, S. R., Watson, R., Ahmed, R. A., Jones, L., Vaselli, M., Wu, M.-S., Hayat, F., Ratcliffe, L., McKenna, M., Hine, P., Defres, S., Wingfield, T.
10.1101/2021.03.23.21253630 — Posted: 2021-03-30
Increased transmissibility of the B.1.1.7 SARS-CoV-2 variant: Evidence from contact tracing data in Oslo, January to February 2021
Lindstrom, J. C., Engebretsen, S., Kristoffersen, A. B., Ro, G. O. I., Palomares, A. D.-L., Engo-Monsen, K., Madslien, E. H., Forland, F., Nygard, K. M., Hagen, F., Wiklund, O., Gantzel, G., Frigessi, A., de Blasio, B. F.
10.1101/2021.03.29.21254122 — Posted: 2021-03-30 Discussion: Offsite
Six-month pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study
Faverio, P., Luppi, F., Rebora, P., Busnelli, S., Stainer, A., Catalano, M., Parachini, L., Monzani, A., Galimberti, S., Bini, F., Bodini, B. D., Betti, M., De Giacomi, F., Scarpazza, P., Oggionni, E., Scartabellati, A., Bilucaglia, L., Ceruti, P., Modina, D., Harari, S., Caminati, A., Valsecchi, M. G., Bellani, G., Foti, G., Pesci, A.
10.1101/2021.03.29.21254151 — Posted: 2021-03-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).